Scinovex
review Open AccessTop 1% cited

Depression and Pain Comorbidity

Archives of Internal Medicine · 2003 · Vol. 163(20) · pp. 2433–2433
Matthew J. BairR.L. RobinsonWayne KatonKurt Kroenke

Abstract

Because depression and painful symptoms commonly occur together, we conducted a literature review to determine the prevalence of both conditions and the effects of comorbidity on diagnosis, clinical outcomes, and treatment. The prevalences of pain in depressed cohorts and depression in pain cohorts are higher than when these conditions are individually examined. The presence of pain negatively affects the recognition and treatment of depression. When pain is moderate to severe, impairs function, and/or is refractory to treatment, it is associated with more depressive symptoms and worse depression outcomes (eg, lower quality of life, decreased work function, and increased health care utilization). Similarly, depression in patients with pain is associated with more pain complaints and greater impairment. Depression and pain share biological pathways and neurotransmitters, which has implications for the treatment of both concurrently. A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes.

Musculoskeletal pain and rehabilitationPain Mechanisms and TreatmentsPain Management and Placebo EffectDepression (economics)ComorbidityMedicineDepressive symptomsQuality of life (healthcare)Chronic painPsychiatryPhysical therapyAnxiety

MeSH terms

Antidepressive AgentsChronic DiseaseDepressionDepressive DisorderHumansPainComorbidityPrevalenceTreatment Outcome

Funding

  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • University of Washington
  • School of Medicine, Indiana University
Citations
3,361
FWCI
22.75
field-weighted impact
References
191
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.